Proprietary AI analyst is now available
- Public Comps
- U.S. Physical Therapy
U.S. Physical Therapy Valuation Multiples
Discover U.S. Physical Therapy's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Nutex Health, WELL Health, Rhoen Klinikum, Life Healthcare Group and more.
U.S. Physical Therapy Overview
About U.S. Physical Therapy
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Founded
1990
HQ

Employees
7.0K
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialU.S. Physical Therapy Financials
U.S. Physical Therapy reported last 12-month revenue of $806M and EBITDA of $99M.
In the same LTM period, U.S. Physical Therapy generated $192M in gross profit, $99M in EBITDA, and $41M in net income.
Revenue (LTM)
U.S. Physical Therapy P&L
In the most recent fiscal year, U.S. Physical Therapy reported revenue of $781M and EBITDA of $110M.
U.S. Physical Therapy is profitable as of last fiscal year, with gross margin of 19%, EBITDA margin of 14%, and net margin of 5%.
Financial data powered by Morningstar, Inc.
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy has current market cap of $940M, and enterprise value of $1B.
Market Cap Evolution
U.S. Physical Therapy's stock price is $61.77.
U.S. Physical Therapy share price decreased by 3.9% in the last 30 days, and by 21.0% in the last year.
U.S. Physical Therapy has an EPS (earnings per share) of $2.63.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $940M | -0.2% | -3.9% | -17.6% | -21.0% | $2.63 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialU.S. Physical Therapy Valuation Multiples
U.S. Physical Therapy trades at 1.6x EV/Revenue multiple, and 12.9x EV/EBITDA.
EV / Revenue (LTM)
U.S. Physical Therapy Financial Valuation Multiples
As of June 5, 2026, U.S. Physical Therapy has market cap of $940M and EV of $1B.
U.S. Physical Therapy has a P/E ratio of 22.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified U.S. Physical Therapy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


U.S. Physical Therapy Margins & Growth Rates
U.S. Physical Therapy grew revenue by 7% but EBITDA decreased by 5% in the last fiscal year.
In the most recent fiscal year, U.S. Physical Therapy reported gross margin of 19%, EBITDA margin of 14%, and net margin of 5%.
U.S. Physical Therapy Margins
U.S. Physical Therapy Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
U.S. Physical Therapy Operational KPIs
U.S. Physical Therapy's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
U.S. Physical Therapy's Rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
U.S. Physical Therapy's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
U.S. Physical Therapy Competitors
U.S. Physical Therapy competitors include Nutex Health, WELL Health, Rhoen Klinikum, Life Healthcare Group, HCG Hospitals, Hangzhou Pinming Software, PHC Holdings, MedicalSystem Technology, B-Soft Co. and Sphere.
Most U.S. Physical Therapy public comparables operate across Hospitals & Clinics, Healthcare Software, B2B SaaS, Vertical SaaS, HealthTech and Longevity.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.2x | 1.2x | 3.7x | 4.4x | |||
| 1.3x | 1.2x | 8.9x | 9.3x | |||
| 0.3x | 0.3x | 4.5x | 4.9x | |||
| 0.7x | 0.7x | 5.0x | 4.5x | |||
| 4.2x | 4.1x | 23.2x | 22.2x | |||
| 15.3x | - | 119.4x | - | |||
| 0.9x | 0.9x | 6.4x | 6.3x | |||
| 22.4x | 20.0x | 75.9x | 87.0x | |||
This data is available for Pro users. Sign up to see all U.S. Physical Therapy competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by U.S. Physical Therapy
U.S. Physical Therapy has acquired 1 company to date.
Last acquisition by U.S. Physical Therapy was on March 1st 2023. U.S. Physical Therapy acquired Momentum Physical Therapy for $8M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by U.S. Physical Therapy
| Description | Momentum Physical Therapy is a clinic delivering personalized one-on-one physical therapy sessions led by certified therapists. Located in Fort Myers, Florida, it treats musculoskeletal conditions through therapeutic exercises, manual therapy, and progress tracking. Patients receive detailed explanations of diagnoses and customized home programs. The practice specializes in sports injuries, post-surgery rehab, and chronic pain management with facilities including private treatment rooms. |
| HQ Country | |
| HQ City | San Antonio, TX |
| Deal Date | 1 Mar 2023 |
| Valuation | $8M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all U.S. Physical Therapy acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout U.S. Physical Therapy
| When was U.S. Physical Therapy founded? | U.S. Physical Therapy was founded in 1990. |
| Where is U.S. Physical Therapy headquartered? | U.S. Physical Therapy is headquartered in United States. |
| How many employees does U.S. Physical Therapy have? | As of today, U.S. Physical Therapy has over 7K employees. |
| Who is the CEO of U.S. Physical Therapy? | U.S. Physical Therapy's CEO is Christopher J. Reading. |
| Is U.S. Physical Therapy publicly listed? | Yes, U.S. Physical Therapy is a public company listed on NYSE. |
| What is the stock symbol of U.S. Physical Therapy? | U.S. Physical Therapy trades under USPH ticker. |
| When did U.S. Physical Therapy go public? | U.S. Physical Therapy went public in 1992. |
| Who are competitors of U.S. Physical Therapy? | U.S. Physical Therapy main competitors include Nutex Health, WELL Health, Rhoen Klinikum, Life Healthcare Group, HCG Hospitals, Hangzhou Pinming Software, PHC Holdings, MedicalSystem Technology, B-Soft Co., Sphere. |
| What is the current market cap of U.S. Physical Therapy? | U.S. Physical Therapy's current market cap is $940M. |
| What is the current revenue of U.S. Physical Therapy? | U.S. Physical Therapy's last 12 months revenue is $806M. |
| What is the current revenue growth of U.S. Physical Therapy? | U.S. Physical Therapy revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of U.S. Physical Therapy? | Current revenue multiple of U.S. Physical Therapy is 1.6x. |
| What is the current EBITDA of U.S. Physical Therapy? | U.S. Physical Therapy's last 12 months EBITDA is $99M. |
| What is U.S. Physical Therapy's EBITDA margin? | U.S. Physical Therapy's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of U.S. Physical Therapy? | Current EBITDA multiple of U.S. Physical Therapy is 12.9x. |
| What is the current FCF of U.S. Physical Therapy? | U.S. Physical Therapy's last 12 months FCF is $63M. |
| What is U.S. Physical Therapy's FCF margin? | U.S. Physical Therapy's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of U.S. Physical Therapy? | Current FCF multiple of U.S. Physical Therapy is 20.3x. |
| How many companies U.S. Physical Therapy has acquired to date? | As of June 2026, U.S. Physical Therapy has acquired 1 company. |
| What was the largest acquisition by U.S. Physical Therapy? | $8M acquisition of Momentum Physical Therapy on 1st March 2023 was the largest M&A U.S. Physical Therapy has done to date. |
| What companies U.S. Physical Therapy acquired? | U.S. Physical Therapy acquired Momentum Physical Therapy. |
| In how many companies U.S. Physical Therapy has invested to date? | U.S. Physical Therapy hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to U.S. Physical Therapy
Lists including U.S. Physical Therapy
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
